Get In Touch

Global Etoposide Market: Description

Etoposide is a derivative of epipodophyllotoxins that are derived from Mandragora officianarum (plant). Its chemical name is 4'-demethyl-epipodophylotoxin 9-[4,6-O-(R)-ethylidene-β-D-glucopyranoside] and it was introduced in the market in 1970. Currently, it is utilized extensively in manufacturing drugs that help treat various human malignant diseases such as testicular cancer, lymphomas (Hodgkin, non-Hodgkin), leukemia and lung cancer. Other diseases that are treated by consumption of etoposide include Ewing sarcoma, Kaposi disease, rhabdomyosarcoma, soft tissue sarcoma, pediatric brain tumors, gastric cancer, Wilms tumor, multiple myeloma, hepatoma, adenocarcinoma and uterine cancer. 

Etoposide acts by inhibiting the activity of topoisomerase II which is responsible for uncoiling of deoxyribonucleic acid (DNA) and thus affects the deoxyribonucleic acid (DNA) replication and repair. Etoposide is usually administered in combination with various antineoplastic drugs such as cisplatin that have different modes of action. Etoposide is administered in the patient’s body through oral and intravenous routes. Intravenous administration of etoposide is given under the supervision of a doctor since overdose of the same might result in malfunctioning of human body. Etoposide solution for injection is available in 5 mL vial, 25 mL vial and 50 mL vial, and the dose is 20 mg/mL. Etoposide injections are usually given to patients whose cancer condition have not improved or have worsened post radiation treatment or other medications.

Global Etoposide Market: Major Products

Etopophos, Toposar and Vepesid are some of the branded versions of the Etoposide. Among all these, Etopophos accounts for the largest revenue share in the total etoposide market. Rising incidence of lung cancer has been considered as one of the major factors driving the market for etoposide. According to the American Lung Association (ALA), an estimated 159,260 people with lung cancer are expected to die in the American region in 2014 that will account for approximately 27% of all cancer deaths in the same year. Also, increasing incidence of Ewing sarcoma will propel the growth of etoposide market.

Global Etoposide Market: Drivers and Restraints

The increasing number of acquired immune deficiency syndrome (AIDS) patients across the globe will further drive the growth of etoposide market as people with AIDS are at the high risk of developing Kaposi’s sarcoma. It has been estimated by the World Health Organization that in 2012, around 35.3 million people were living with AIDS worldwide; of these around 1.6 million people died. AIDS also increases the risk for Hodgkin and non-Hodgkin syndrome. Increasing number of patients suffering with gastric cancer will also augment the growth of etoposide market. Various epidemiological sources indicate that around 1 million people suffer from gastric cancer every year across the globe. Despite all the advantages, the growth of etoposide market might get hampered due to the side effects associated with the administration of etoposide. Difficulty in breathing or swallowing, seizures, hives, constipation, hair loss and unusual tiredness or weakness are some of the side-effects that are associated with etoposide.

Global Etoposide Market: Geographical Dynamics

North America accounted for the largest revenue share of the total etoposide market in 2012 owing to the presence of major manufacturing companies in the region along with the improving governmental initiatives for the development and manufacturing of etoposide. Asia-Pacific is expected to show highest CAGR during the forecast period. This growth is attributed to rising incidences of various diseases such as uterine cancer, multiple myeloma, hepatoma and lymphoma in the region. Increasing government funding for the R&D of etoposide will further drive the growth of etoposide market in the region. Major players operating in the market includes Pharmedic Laboratories Pvt. Ltd, Teva Pharmaceutical Industries Ltd, Ben Venue Laboratories, and Accord Healthcare, Inc. among other significant players.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Etoposide Market

Pre Book